Cambridge Investment Research Advisors’s Vapotherm, Inc. Common Stock VAPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-17,543
Closed -$44K 3332
2023
Q3
$44K Sell
17,543
-1
-0% -$3 ﹤0.01% 3049
2023
Q2
$62K Sell
17,544
-26
-0.1% -$119 ﹤0.01% 3067
2023
Q1
$93K Hold
17,570
﹤0.01% 2973
2022
Q4
$380K Buy
17,570
+9,375
+114% +$107K ﹤0.01% 2246
2022
Q3
$103K Buy
8,195
+2,500
+44% +$39K ﹤0.01% 2851
2022
Q2
$115K Buy
5,695
+1,276
+29% +$46.7K ﹤0.01% 2844
2022
Q1
$491K Hold
4,419
﹤0.01% 2109
2021
Q4
$732K Buy
4,419
+44
+1% +$7.62K ﹤0.01% 1801
2021
Q3
$779K Hold
4,375
﹤0.01% 1727
2021
Q2
$827K Buy
4,375
+1,206
+38% +$206K ﹤0.01% 1674
2021
Q1
$609K Hold
3,169
﹤0.01% 1756
2020
Q4
$681K Buy
3,169
+44
+1% +$9.81K ﹤0.01% 1564
2020
Q3
$725K Sell
3,125
-1,009
-24% -$291K ﹤0.01% 1373
2020
Q2
$1.36M Buy
4,134
+1,009
+32% +$213K 0.01% 956
2020
Q1
$471K Hold
3,125
﹤0.01% 1392
2019
Q4
$304K Buy
+3,125
New +$264K ﹤0.01% 1906

Other funds holding VAPO

Cambridge Investment Research Advisors's VAPO Position: Q4 2023 in Review

Cambridge Investment Research Advisors sold out of Vapotherm, Inc. Common Stock (VAPO) in Q4 2023, closing a stake of 17,543 shares — an estimated $44K sold.

Cambridge Investment Research Advisors first reported a position in VAPO in Q4 2019 and held it in 16 quarters. The position peaked at $1.36M in Q2 2020. 3 funds tracked by Wall St. Rank hold VAPO as of Q4 2023.

  • Cambridge Investment Research Advisors reported no remaining Vapotherm, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 17,543 Vapotherm, Inc. Common Stock shares in Q4 2023, an estimated $44K.
  • Cambridge Investment Research Advisors first reported a position in Vapotherm, Inc. Common Stock in Q4 2019 and held it in 16 quarters.
  • Cambridge Investment Research Advisors's Vapotherm, Inc. Common Stock position peaked at $1.36M in Q2 2020.
  • 3 funds tracked by Wall St. Rank held Vapotherm, Inc. Common Stock as of Q4 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.